China · Delayed Price · Currency is CNY Obio Technology (Shanghai) Corp. Company Description
Obio Technology (Shanghai) Corp., Ltd., a biotechnology company, engages in the provision of technical services for the field of regenerative medicine and anti-aging in China.
The company offers customized plasmid design and viral vector packaging services; AAV serotypes and tissue-specific promoters to support scientific research; and research grade, NHP Grade, cGMP grade vector manufacturing process, for basic research, translational research and clinical trials.
It also provides CDMO services encompassing process development, analytical methods, IND-enabling chemistry, manufacturing, and controls; and clinical and commercial manufacturing for viral vector, oncolytic virus, and cell therapy products.
The company was founded in 2013 and is headquartered in Shanghai, China.
| Country | China |
| Founded | 2013 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 692 |
| CEO | Oudong Pan |
Contact Details
Address: International Medical Park Shanghai, 201321 China | |
| Phone | 86 21 5858 5887 |
| Website | obiosh.com |
Stock Details
| Ticker Symbol | 688238 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Oudong Pan | Founder, Chairman of the Board and GM |
| Luyuan Xu | Deputy GM, Chief Financial Officer, Accounting Supervisor and Board Secretary |
| Junyi Pan | Investment Director, GM of Regenerative Medicine Division and Director |
| Fujie Wang | Vice President of Supply Chain and Information Technology and Director |
| Shan Yin | Deputy GM and Director |
| Qingmei Xia | Deputy General Manager |
| Qinbin Wu | Deputy General Manager |
| Xinglin Yang | R and D Director |
| Jiali Yang | Deputy Director of Research & Development |
| Houliang Wei | Vice President of Process Development |